Comprehensive Stock Comparison
Compare MDB Capital Holdings, LLC Class A common (MDBH) vs Nomura Holdings, Inc. (NMR) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | NMR | 13.4% revenue growth vs MDBH's -47.5% |
| Value | MDBH | Lower P/E (1.2x vs 11.3x) |
| Quality / Margins | MDBH | 5.3% net margin vs NMR's 7.6% |
| Stability / Safety | MDBH | Beta 0.39 vs NMR's 1.19, lower leverage |
| Dividends | NMR | 2.6% yield; 2-year raise streak; MDBH pays no meaningful dividend |
| Momentum (1Y) | NMR | +45.9% vs MDBH's -53.5% |
| Efficiency (ROA) | MDBH | 18.6% ROA vs NMR's 0.6%, ROIC -38.9% vs 1.0% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
MDB Capital Holdings operates as a specialized financial services firm with a dual focus on investment banking and technology development. It generates revenue primarily through its broker-dealer segment — conducting private and public securities offerings — while also pursuing synthetic biology technology development as a secondary business line. The company's competitive advantage lies in its unique combination of financial services expertise with direct technology development capabilities, creating a specialized niche in funding and developing early-stage synthetic biology ventures.
Nomura Holdings is a Japanese financial services conglomerate that operates as a full-service investment bank and securities firm. It generates revenue primarily through its Wholesale segment — investment banking, trading, and securities underwriting — which contributes roughly 60-70% of total revenue, supplemented by Retail brokerage and Investment Management services. The company's key advantage is its dominant position in Japan's domestic capital markets and its extensive Asian franchise, which provides deep client relationships and local market expertise.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
NMR leads in 3 of 6 categories (Financial Metrics, Total Returns). MDBH leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
Financial Metrics (TTM)
NMR is the larger business by revenue, generating $4.51T annually — 2029447.6x MDBH's $2M. Profitability is closely matched — net margins range from 5.3% (MDBH) to 7.6% (NMR).
| Metric | MDBHMDB Capital Holdi… | NMRNomura Holdings, … |
|---|---|---|
| RevenueTrailing 12 months | $2M | $4.51T |
| EBITDAEarnings before interest/tax | -$24M | $533.0B |
| Net IncomeAfter-tax profit | $11M | $370.1B |
| Free Cash FlowCash after capex | -$4M | $0 |
| Gross MarginGross profit ÷ Revenue | -8.0% | +36.9% |
| Operating MarginEBIT ÷ Revenue | -12.9% | +10.5% |
| Net MarginNet income ÷ Revenue | +5.3% | +7.6% |
| FCF MarginFCF ÷ Revenue | -3.8% | -19.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +43.4% | -5.5% |
Valuation Metrics
At 1.2x trailing earnings, MDBH trades at a 91% valuation discount to NMR's 12.7x P/E.
| Metric | MDBHMDB Capital Holdi… | NMRNomura Holdings, … |
|---|---|---|
| Market CapShares × price | $16M | $26.6B |
| Enterprise ValueMkt cap + debt − cash | -$4M | $192.1B |
| Trailing P/EPrice ÷ TTM EPS | 1.19x | 12.66x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.35x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.16x |
| EV / EBITDAEnterprise value multiple | — | 56.19x |
| Price / SalesMarket cap ÷ Revenue | 7.05x | 0.92x |
| Price / BookPrice ÷ Book value/share | 0.20x | 1.20x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
MDBH delivers a 19.2% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $10 for NMR. MDBH carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to NMR's 8.75x. On the Piotroski fundamental quality scale (0–9), NMR scores 7/9 vs MDBH's 5/9, reflecting strong financial health.
| Metric | MDBHMDB Capital Holdi… | NMRNomura Holdings, … |
|---|---|---|
| ROE (TTM)Return on equity | +19.2% | +10.3% |
| ROA (TTM)Return on assets | +18.6% | +0.6% |
| ROICReturn on invested capital | -38.9% | +1.0% |
| ROCEReturn on capital employed | -51.8% | +2.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.01x | 8.75x |
| Net DebtTotal debt minus cash | -$20M | $25.83T |
| Cash & Equiv.Liquid assets | $20M | $5.51T |
| Total DebtShort + long-term debt | $711,503 | $31.35T |
| Interest CoverageEBIT ÷ Interest expense | -399.73x | 0.20x |
Total Returns (with DRIP)
A $10,000 investment in NMR five years ago would be worth $16,957 today (with dividends reinvested), compared to $2,506 for MDBH. Over the past 12 months, NMR leads with a +45.9% total return vs MDBH's -53.5%. The 3-year compound annual growth rate (CAGR) favors NMR at 33.4% vs MDBH's -37.0% — a key indicator of consistent wealth creation.
| Metric | MDBHMDB Capital Holdi… | NMRNomura Holdings, … |
|---|---|---|
| YTD ReturnYear-to-date | -10.5% | +6.5% |
| 1-Year ReturnPast 12 months | -53.5% | +45.9% |
| 3-Year ReturnCumulative with dividends | -74.9% | +137.6% |
| 5-Year ReturnCumulative with dividends | -74.9% | +69.6% |
| 10-Year ReturnCumulative with dividends | -74.9% | +160.8% |
| CAGR (3Y)Annualised 3-year return | -37.0% | +33.4% |
Risk & Volatility
MDBH is the less volatile stock with a 0.39 beta — it tends to amplify market swings less than NMR's 1.19 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NMR currently trades 93.9% from its 52-week high vs MDBH's 44.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | MDBHMDB Capital Holdi… | NMRNomura Holdings, … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.39x | 1.19x |
| 52-Week HighHighest price in past year | $6.98 | $9.58 |
| 52-Week LowLowest price in past year | $3.00 | $4.86 |
| % of 52W HighCurrent price vs 52-week peak | +44.9% | +93.9% |
| RSI (14)Momentum oscillator 0–100 | 41.6 | 53.1 |
| Avg Volume (50D)Average daily shares traded | 8K | 1.1M |
Analyst Outlook
NMR is the only dividend payer here at 2.61% yield — a key consideration for income-focused portfolios.
| Metric | MDBHMDB Capital Holdi… | NMRNomura Holdings, … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $5.79 |
| # AnalystsCovering analysts | — | 9 |
| Dividend YieldAnnual dividend ÷ price | — | +2.6% |
| Dividend StreakConsecutive years of raises | 1 | 2 |
| Dividend / ShareAnnual DPS | — | $36.70 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.4% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Sep 23 | Feb 26 | Change |
|---|---|---|---|
| MDB Capital Holding… (MDBH) | 100 | 25.6 | -74.4% |
| Nomura Holdings, In… (NMR) | 100 | 214.96 | +115.0% |
Nomura Holdings, In… (NMR) returned +70% over 5 years vs MDB Capital Holding… (MDBH)'s -75%. A $10,000 investment in NMR 5 years ago would be worth $16,957 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| MDB Capital Holding… (MDBH) | $0.00 | $2M | — |
| Nomura Holdings, In… (NMR) | $1.6T | $4.5T | +187.9% |
Nomura Holdings, Inc.'s revenue grew from $1.6T (2016) to $4.5T (2025) — a 12.5% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| MDB Capital Holding… (MDBH) | -4.8% | 5.3% | +210.5% |
| Nomura Holdings, In… (NMR) | 8.4% | 7.6% | -10.0% |
Nomura Holdings, Inc.'s net margin went from 8% (2016) to 8% (2025).
Chart 4P/E Ratio History — 8 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Nomura Holdings, In… (NMR) | 0.1 | 0.1 | +0.0% |
Nomura Holdings, Inc. has traded in a 0x–0x P/E range over 8 years; current trailing P/E is ~13x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| MDB Capital Holding… (MDBH) | -0.09 | 2.64 | +3195.0% |
| Nomura Holdings, In… (NMR) | 35.52 | 111.03 | +212.6% |
Nomura Holdings, Inc.'s EPS grew from $35.52 (2016) to $111.03 (2025) — a 14% CAGR.
Chart 6Free Cash Flow — 5 Years
MDB Capital Holdings, LLC Class A common generated $-8M FCF in 2024 (-36% vs 2021). Nomura Holdings, Inc. generated $-869B FCF in 2025 (-259% vs 2021).
MDBH vs NMR: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is MDBH or NMR a better buy right now?
MDB Capital Holdings, LLC Class A common (MDBH) offers the better valuation at 1.2x trailing P/E, making it the more compelling value choice. Analysts rate Nomura Holdings, Inc. (NMR) a "Hold" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MDBH or NMR?
On trailing P/E, MDB Capital Holdings, LLC Class A common (MDBH) is the cheapest at 1.2x versus Nomura Holdings, Inc. at 12.7x.
03Which is the better long-term investment — MDBH or NMR?
Over the past 5 years, Nomura Holdings, Inc. (NMR) delivered a total return of +69.6%, compared to -74.9% for MDB Capital Holdings, LLC Class A common (MDBH). A $10,000 investment in NMR five years ago would be worth approximately $17K today (assuming dividends reinvested). Over 10 years, the gap is even starker: NMR returned +160.8% versus MDBH's -74.9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MDBH or NMR?
By beta (market sensitivity over 5 years), MDB Capital Holdings, LLC Class A common (MDBH) is the lower-risk stock at 0.39β versus Nomura Holdings, Inc.'s 1.19β — meaning NMR is approximately 209% more volatile than MDBH relative to the S&P 500. On balance sheet safety, MDB Capital Holdings, LLC Class A common (MDBH) carries a lower debt/equity ratio of 1% versus 9% for Nomura Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which has better profit margins — MDBH or NMR?
MDB Capital Holdings, LLC Class A common (MDBH) is the more profitable company, earning 526.5% net margin versus 7.6% for Nomura Holdings, Inc. — meaning it keeps 526.5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NMR leads at 10.5% versus -1289.4% for MDBH. At the gross margin level — before operating expenses — NMR leads at 36.9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — MDBH or NMR?
In this comparison, NMR (2.6% yield) pays a dividend. MDBH does not pay a meaningful dividend and should not be held primarily for income.
07Is MDBH or NMR better for a retirement portfolio?
For long-horizon retirement investors, MDB Capital Holdings, LLC Class A common (MDBH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.39)). Both have compounded well over 10 years (MDBH: -74.9%, NMR: +160.8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between MDBH and NMR?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. NMR pays a dividend while MDBH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.